SanBio Company Limited
STEMTRA(STEM cell therapy for TRAumatic brain injury)
Phase 2 TBI-01 study with SB623 Result update
This presentation material, including any comments made during or following the presentation, is provided solely for the purpose of reference to those investors who make their own evaluation of the company at their own risk.
Please check Youtube Movie